These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 15777517

  • 1. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW, Meusser-Storm S, Eger G.
    Allergol Immunopathol (Madr); 2005; 33(1):7-14. PubMed ID: 15777517
    [Abstract] [Full Text] [Related]

  • 2. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of hymenoptera venom immunotherapy.
    Kayikci H, Bostan OC, Tuncay G, Cihanbeylerden M, Damadoglu E, Karakaya G, Kalyoncu AF.
    Allergy Asthma Proc; 2024 Jul 01; 45(4):268-275. PubMed ID: 38982604
    [Abstract] [Full Text] [Related]

  • 4. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 5. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D, Bircher AJ, Scherer K.
    J Investig Allergol Clin Immunol; 2011 Oct 17; 21(1):22-7. PubMed ID: 21370719
    [Abstract] [Full Text] [Related]

  • 6. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C, Miehe U, Treudler R, Kiess W, Prenzel F.
    Int Arch Allergy Immunol; 2017 Oct 17; 172(3):167-172. PubMed ID: 28380475
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A, Confino-Cohen R.
    J Allergy Clin Immunol; 2001 May 17; 107(5):902-6. PubMed ID: 11344360
    [Abstract] [Full Text] [Related]

  • 9. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA, Salinas L J, Toche P P, Marinovic M MA, Gallardo O AM.
    Rev Med Chil; 2007 Dec 17; 135(12):1566-71. PubMed ID: 18357358
    [Abstract] [Full Text] [Related]

  • 10. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM, Durham SR.
    Front Immunol; 2019 Dec 17; 10():1959. PubMed ID: 31497015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ultrarush immunotherapy in patients with Hymenoptera venom allergy.
    Ruëff F, Przybilla B.
    J Allergy Clin Immunol; 2001 May 17; 107(5):928-9. PubMed ID: 11344369
    [No Abstract] [Full Text] [Related]

  • 13. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R, Glück J, Jawor B, Rogala B.
    Immunopharmacol Immunotoxicol; 2015 May 17; 37(4):375-9. PubMed ID: 26181651
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hymenoptera venom allergy.
    Przybilla B, Ruëff F.
    J Dtsch Dermatol Ges; 2010 Feb 17; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.